• About us
  • Membership
  • Contact us
  • Wed November 5, 2025

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

spinal muscular atrophy

Total:2

  • Oral medicine for SMA patients delivered to Iran 2022-08-09 18:47

    Oral medicine for SMA patients delivered to Iran

    TEHRAN – The first shipment of Evrysdi, an oral medication used to treat spinal muscular atrophy (SMA), has been imported to the country, Saeed Azamian, CEO of the SMA Association of Iran, said on Tuesday.

  • FDA imports medicine for SMA patients 2022-08-02 18:57

    FDA imports medicine for SMA patients

    TEHRAN – The first batch of SPINRAZA – a drug special for patients suffering from spinal muscular atrophy (SMA) - has arrived in the country, the Food and Drug Administration director announced on Tuesday.

All Pages

Latest

  • Over 1.4 million people donate blood in 7 months  

  • Iran’s Valizadeh runner-up at 2025 Heyball World Champion

  • Iran, Kuwait move to clear trade barriers in joint committee talks

  • Iran’s railway emerges as key transit link between India, Russia

  • Quintessential rogues gallery — US, Western Europe, Canada, Australia, with Arab and Muslims in tow

  • Iran handed easy draw at AFC Futsal Asian Cup 2026

  • Mehrabad Airport Terminal 2: Complete Guide

  • Iran volleyball star Saber Kazemi passes away

  • 15189

  • Sepahan, Ahal settle for draw: 2025/26 ACL Two

  • Woody Allen’s “Annie Hall” to be shown in Tehran cultural center

  • Virginia to host group exhibition of Iranian artists

  • Global animators invited to showcase work at Tehran Intl. Animation Festival

  • Iranian short film “Unit 13” wins in Spanish festival

  • Why are multiple mediators active simultaneously?

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio